Pfizer Revives Weight-Loss Pill to Challenge Obesity Drug Leaders
Pfizer announces a surprising turnaround in its weight-loss strategy, advancing two new daily pills in a heated battle for the lucrative obesity drug market dominated by injectables.
Category : Search result: unlicensed pharmaceuticals
'Youth Pill' Targets Brain Aging in Dementia Breakthrough
A groundbreaking pill from Retro Biosciences promises to reverse brain aging and combat dementia. Early human trials show potential to revolutionise Alzheimer's treatment. Discover the science behind this medical marvel.
UK signs deal for Merck's groundbreaking Covid-19 pill
The UK government has secured 250,000 courses of Merck's molnupiravir, an innovative antiviral pill shown to halve hospitalisations in a major scientific breakthrough.
Eli Lilly shuts London research centre in major UK science blow
In a significant setback for British research, pharmaceutical titan Eli Lilly is closing its London research and development hub, putting over 100 jobs at risk and raising concerns about the UK's post-Brexit scientific competitiveness.
Pharma Giant Cuts 9,000 Jobs in Major Restructure
A major pharmaceutical multinational has announced a drastic cost-cutting plan, putting 9,000 roles at risk globally. The move signals deepening turmoil within the industry, raising concerns for the UK's strategic life sciences sector.
Novo Nordisk's £90m UK Expansion for Ozempic Production
Danish pharmaceutical giant Novo Nordisk announces major £90 million expansion at its Gatwick facility to meet soaring global demand for its blockbuster diabetes and weight-loss drugs, Ozempic and Wegovy, creating new high-skilled jobs.
Novo Nordisk cuts 9,000 jobs amid Ozempic competition
Danish pharmaceutical giant Novo Nordisk announces major restructuring, cutting 9,000 jobs globally. The move comes as competition intensifies in the lucrative weight-loss and diabetes drug market, challenging its blockbuster medications Ozempic and Wegov
Gates Foundation invests $40m in African vaccine production
The Bill & Melinda Gates Foundation announces a major $40m investment in Nigerian and Senegalese vaccine production, aiming to boost Africa's pharmaceutical sovereignty and pandemic resilience.
From Vet to Vet: The Canine Diabetes Drug Changing Human Lives
The incredible story of exenatide, a diabetes medication developed for dogs, that is now revolutionising human weight loss treatments and reshaping our understanding of obesity.
Streeting Confronts Pharma Giants Over NHS Drug Pricing
Health Secretary Wes Streeting confronts major pharmaceutical firms, demanding transparency and fair pricing in the NHS's voluntary rebate scheme, which recouped £1.4bn last year.
Fake Florida Dentist Arrested For Unlicensed Procedures
A Florida man has been arrested for posing as a dentist and performing unauthorised procedures on patients, including tooth extractions, without any medical licence or training.
Eli Lilly reduces Mounjaro price in UK after Trump criticism
Pharmaceutical giant Eli Lilly reduces the UK price of its weight-loss drug Mounjaro following backlash, including criticism from former US President Donald Trump.
Fake nurse treated 4,000 patients without license
A woman in Florida posed as a licensed nurse for over a decade, treating thousands of patients despite having no medical qualifications. Authorities are now investigating how she evaded detection for so long.
RFK Jr cancels mRNA vaccine development
Robert F. Kennedy Jr cancels plans to develop mRNA vaccines, citing safety concerns and ethical issues. Read the latest updates on this controversial decision.
Male contraceptive pill trial shows promise despite side effects
A new male contraceptive pill shows high efficacy in trials, though some participants reported side effects. Could this revolutionise birth control?
EU probes Swiss pharma over Trump-era deals
European Union investigates Swiss pharmaceutical firms Roche and Novartis for potential antitrust violations in deals connected to Donald Trump's administration.
European pharma firms blast Trump's medicine tariffs
Leading European pharmaceutical firms have condemned the Trump administration's new tariffs on medicines, warning they will drive up costs and limit access to vital treatments.
Rogue Botox injectors putting lives at risk
Shocking investigation reveals unqualified practitioners administering dangerous Botox treatments, leading to severe health complications. Experts warn of the growing black market in cosmetic procedures.
UK pharma may dodge Trump's steel tariffs
Former US President Donald Trump's proposed tariffs on UK steel exports may be offset by concessions for the British pharmaceutical industry, according to insider reports.
NHS England secures cystic fibrosis drug deal
NHS England secures deal to expand access to Orkambi for cystic fibrosis patients after prolonged negotiations with Vertex Pharmaceuticals.
UK's £3.2bn illegal cosmetic surgery trade exposed
A damning report reveals the UK's underground cosmetic surgery industry is booming, with unlicensed practitioners putting lives at risk. Experts warn of dire consequences.
Page 2 of 2